Mandate

Enhance Greater Montréal’s productivity and competitiveness of Greater Montréal in terms or research and development (R&D) and promote the increase in public and private investments in R&D.

Achievements

  • Strategic thinking for the identification of the attributes of a new structuring research and development project
  • Identify strategic priorities improving Québec’s competitiveness in order to develop diagnostic and therapeutic innovations for rare diseases

 

For more information about this strategic commitee, please read about it in the most recent Activity Report.

 

  • Survey the medical Cannabis industrial players to better understand the environment and opportunities
  • Develop a fourth page of “niche of excellence” on artificial intelligence applied to life sciences and health technologies

Members of the Strategic Committee

Coordinator of the Strategic Committee

Nathalie Ouimet

Vice-president
  • Vratislav Hadrava, Coprésident
    Pfizer Canada
  • Serge Marchand, Coprésident
    Fonds de Recherche du Québec- Santé
  • Carl-Éric Aubin
    TransMedTech et École Polytechnique
  • Christian Baron
    Université de Montréal
  • Nadine Beauger
    Institut de Recherche en Immunologie et en Cancérologie, Commercialisation de la recherche
  • Frank Béraud
    Montréal InVivo
  • Marco Blouin
    Ministry of Economy, Science and Innovation, Government of Québec
  • Mario Chevrette
    Consortium québécois sur la découverte du médicament
  • Jacques de Guise
    École des Technologies Supérieures et Centre Hospitalier de l’Université de Montréal
  • Danika Laberge
    CATALIS Québec
  • Monique Lacroix
    Novartis Pharma
  • Stéphanie Lord-Fontaine
    Oncopole
  • Grazia Maion
    Univalor
  • Nolwenn Noisel
    CartaGene
  • Viviane Poupon
    Institut neurologique de Montréal
  • Manon St-Pierre
    Ministry of Health and Social Services
  • Laurent Tillement
    Servier Canada